Acorn Biolabs secures $3.3M seed financing
2019-01-16
Acorn Biolabs raised $3.3 million in seed funding from Real Ventures, Globalive Technology, Pool Global Partners and Epic Capital Management and other unnamed partners. Read More →
Avicanna to go public on CSE
2019-01-14
Avicanna filed preliminary non-offering preliminary prospectus and targets to list its shares on the Canadian Securities Exchange (CSE)Read More →
BDC Capital sells US $5.6K Clementia Pharmaceuticals shares
2019-01-13
BDC Capital sold a grand total of 396 common shares of Clementia Pharmaceuticals (NASDAQ: CMTA) for US $5,582.65.Read More →
FACIT’s Compass Rose Oncology Fund invests in DNAstack
2019-01-10
Fight Against Cancer Innovation Trust (FACIT) made follow-on investment in DNAstack through Compass Rose Oncology FundRead More →
Power Corporation’s Sagard Holdings launches Sagard Healthcare Royalty Partners
2019-01-07
Power Corporation’s Sagard Holdings launched Sagard Healthcare Royalty Partners (SHRP) with hiring of David MacNaughtan, Ali Alagheband and Raja Manchanda, former DRI Capital investment professionals Read More →
OrbiMed leads $35M PIPE financing in BELLUS, becomes largest shareholder
2018-12-18
BELLUS Health (TSX: BLU) raised $35M from OrbiMed Advisors, Leaf Venture Partners, First Manhattan Co., Samsara BioCapital, Fonds de solidarité FTQ, AppleTree Partners and Amzak HealthRead More →
OG DNA Genetics secures US $35M funding
2018-12-04
OG DNA Genetics raised US $35 million in two rounds of financing closed in October and November. KES 7 Capital Inc. acted as placement agent and DLA Piper (Canada) LLP acted as legal counselRead More →
Feldan secures additional $1.3M Series A funding from Asahi Kasei
2018-11-27
Feldan Therapeutics raised $1.3 million in additional Series A funding from Asahi Kasei Corporate Venture Capital, the corporate investment arm of Asahi Kasei Corporation (TSE: 3407)Read More →
TILT Holdings closes US $119M financing and to list on CSE
2018-11-21
Baker Technologies, Briteside Holdings, Sea Hunter Therapeutics, and Santé Veritas (CSE: SV) completed merger and US $119M financing with resulting issuer to trade on CSE by end of the month.Read More →
Gotham Green Partners invests US $32M in Cannex Capital
2018-11-21
Cannex Capital Holdings (CSE: CNNX; OTCQX: CNXXF) secured US $32M from New York and California based Gotham Green Partners through the issuance of senior secured convertible notesRead More →
Aleafia and Serruya Private Equity finalize JV and financing agreement
2018-11-21
Aleafia Health Inc. (TSX-V: ALEF; OTCQX: ALEAF; FSE: ARAH) and Serruya Private Equity reached agreement on joint ventures and $10 million private placement financing Read More →
Ampersand closes NEOMED-LABS add-on acquisition of Pacific Biomarkers
2018-11-19
Ampersand Capital Partners completed NEOMED-LABS’ first add-on acquisition, acquiring Seattle’s Pacific BiomarkersRead More →
